Astellas Pharma Inc.

Astellas Pharma Inc.

2,512.00
JPY
+24.50
(+0.98%)
2.59TMarket Cap
Nov 04Next Earn

Latest Stock Split

Mar 27, 2014

5:1

For every share held, investors received 5. The price per share adjusted from $5920.00 to $1184.00.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Mar 27, 2014
    Before$5920.00
    Split ratio5:1
    After$1184.00
    Forward
  2. Mar 26, 1991
    Before—
    Split ratio11:10
    After—
    Forward
  3. Dec 24, 1988
    Before—
    Split ratio11:10
    After—
    Forward
  4. Dec 26, 1985
    Before—
    Split ratio27:25
    After—
    Forward

About Astellas Pharma Inc. stock splits

Astellas Pharma Inc. (TSE:4503) operates in the Pharmaceuticals: major industry.

Astellas Pharma Inc. company overview

When did Astellas Pharma Inc. stock split?

Astellas Pharma Inc.'s most recent stock split was on March 27, 2014. It was a 5-for-1 forward split, so shareholders received 5 shares for every share they held.

What is Astellas Pharma Inc.'s stock split history?

Astellas Pharma Inc. (TSE:4503) has split its stock 4 times: a 27-for-25 split on December 26, 1985, a 11-for-10 split on December 24, 1988, a 11-for-10 split on March 26, 1991, and a 5-for-1 split on March 27, 2014.

How many times has Astellas Pharma Inc. stock split?

Astellas Pharma Inc. has split its stock 4 times. This history records 4 forward splits between December 26, 1985 and March 27, 2014.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Astellas Pharma Inc.'s 5-for-1 split on March 27, 2014, every share became 5 shares.

Will Astellas Pharma Inc. split its stock again?

Astellas Pharma Inc. has not announced a new split in our records. Its most recent split was on March 27, 2014, 12 years ago. Companies announce splits in advance, and any new TSE:4503 split will appear on this page.